Cellulose (Dissolving Pulp) Manufacturing Processes and Properties: A Mini-Review

The increasing consumption of regenerated cellulose, in particular the viscose fiber, has led to a significant development of dissolving pulps in the last decade. In this review paper, the current status of dissolving pulp with respects to raw materials, manufacturing processes, and some key issues are discussed. Non-wood materials and the process concept of upgrading paper-grade pulp into dissolving pulp are also included. Some recent developments related to the analytical methods of the purity and molecular weight distribution based on the ion chromatography and gel permeation chromatography are discussed. Finally, further processing improvements of purification, such as mechanical, chemical, and enzymatic treatment, and their combinations during the manufacturing process of dissolving pulp, are included

Scalable production of tissue-like vascularized liver organoids from human PSCs

The lack of physiological parity between 2D cell culture and in vivo culture has led to the development of more organotypic models, such as organoids. Organoid models have been developed for a number of tissues, including the liver. Current organoid protocols are characterized by a reliance on extracellular matrices (ECMs), patterning in 2D culture, costly growth factors and a lack of cellular diversity, structure, and organization. Current hepatic organoid models are generally simplistic and composed of hepatocytes or cholangiocytes, rendering them less physiologically relevant compared to native tissue. We have developed an approach that does not require 2D patterning, is ECM independent, and employs small molecules to mimic embryonic liver development that produces large quantities of liver-like organoids. Using single-cell RNA sequencing and immunofluorescence, we demonstrate a liver-like cellular repertoire, a higher order cellular complexity, presenting with vascular luminal structures, and a population of resident macrophages: Kupffer cells. The organoids exhibit key liver functions, including drug metabolism, serum protein production, urea synthesis and coagulation factor production, with preserved post-translational modifications such as N-glycosylation and functionality. The organoids can be transplanted and maintained long term in mice producing human albumin. The organoids exhibit a complex cellular repertoire reflective of the organ and have de novo vascularization and liver-like function. These characteristics are a prerequisite for many applications from cellular therapy, tissue engineering, drug toxicity assessment, and disease modeling to basic developmental biology.</p